(Reuters) – North Korea is expected to receive nearly two million doses of AstraZeneca-Oxford COVID-19 vaccine by the first half of 2021, Yonhap reported on Thursday, citing a report published by COVAX Facility on Wednesday. https://bit.ly/3tq6JpR
The COVAX Facility will distribute 1.992 million doses of AstraZeneca/Oxford vaccines produced by the Serum Institute of India to the North Korea by the first half, the news report said.
(Reporting by Anirudh Saligrama in Bengaluru; Editing by Kim Coghill)
